Market Analysis by covering: Pfizer Inc. Read 's Market Analysis on Investing.com ...

Market Strategy - Novo Nordisk is undercutting Eli Lilly on obesity drugs for cash-pay patients [1] - The company aims to regain a larger share of the US market [1]

Market Dynamics - Novo shares 上涨，因该公司退出了对肥胖症药物开发商 Metsera 价值 100 亿美元的收购战 [1]

Industry News - Trump announces steep discounts on obesity drugs [1] Market Impact - Potential impact on pharmaceutical companies and healthcare providers [1]